Home » Topics » BioWorld Science

BioWorld Science
RSS

Sugen initiates phase II prostate cancer trial with SU-101

Dec. 5, 1997

Preclinical results reported for JTE-522, a selective COX-2 inhibitor

Dec. 5, 1997

Genta to evaluate G-3139 in U.S. prostate cancer trial

Dec. 5, 1997

FR-173657 effective in models of kinin-dependent inflammation

Dec. 5, 1997

FDA clears IND for ImmuLogic's cocaine vaccine

Dec. 5, 1997

OR-1384 at least equieffective to 5-ASA in acute and chronic colitis in mice

Dec. 5, 1997

NIH offers licenses for method for diagnosing alpha-thalassemia

Dec. 5, 1997

Gene causing familial Mediterranean fever identified, available for licensing

Dec. 5, 1997

Therapeutic Antibodies: Q3 1997 highlights

Dec. 5, 1997

Medarex reports novel method for treating infectious disease

Dec. 5, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...